COVID-19 and its potential effect on patients with rheumatic diseases in Latin America

Vista sencilla de ítem
dc.date.accessioned2023-04-05T12:48:28Z
dc.date.available2023-04-05T12:48:28Z
dc.date.issued2020
dc.description.abstractThe COVID-19 (coronavirus disease 2019) pandemic has dramatically affected the entire world. Because of significant disparity levels in Latin American countries with deficient health care access and significant poverty, their population may end up among the most severely impacted. Patients with chronic conditions such as rheumatic diseases are quite vulnerable because of their high flaring risks and subsequent poor outcomes. Additionally, an overuse of antimalarials for the treatment of COVID-19 could lead to shortages in our region. Telemedicine, personal protective equipment use by patients and providers, web conferences, and comprehensive care are tools that will contribute to reduce the risk of infections and other complications in rheumatic disease patients, as well as to improve the knowledge and experience of rheumatologists at a global level. © Wolters Kluwer Health, Inc. All rights reserved.
dc.identifier.issn10761608
dc.identifier.urihttps://doi.org/10.1097/RHU.0000000000001493
dc.identifier.urihttp://146.190.124.33/handle/123456789/6388
dc.language.isoenges_ES
dc.publisherLippincott Williams and Wilkinses_ES
dc.sourceRevista de Biología Tropical; Vol. 69 Núm. 4
dc.titleCOVID-19 and its potential effect on patients with rheumatic diseases in Latin Americaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersion
Archivos
Colecciones
Artículo